Q1 2023 Results slide image

Q1 2023 Results

Company overview Innovation: Pipeline overview Financial review Financial performance Appendix Conclusions Appendix Innovation: Clinical trials References Abbreviations 31 Investor Relations | Q1 2023 Results NOVARTIS | Reimagining Medicine
View entire presentation